• Erleada Approved in Europe for Castration-resistant Prostate Cancer Patients at High Risk of Metastasis
  • Coffee and Tea Intake Not Linked to Prostate Cancer Risk, According to Large European Study
  • Prostate Cancer Scoring Method May Not Accurately Predict Outcomes in Black Men, Study Suggests
  • Phase 2 Trial of Tomivosertib Begins Dosing Advanced Castration-resistant PC Patients
  • Phase 2 Trial Assessing CPI-1205, Plus Xtandi, Begins Dosing Metastatic CRPC Patients
  • Trial Studies Gold Nanoparticles as Way to Eliminate Localized Prostate Cancer
  • Top 10 Prostate Cancer Stories of 2018
  • 10-Year Survival of Young Low- and Intermediate-risk Prostate Cancer Patients Better with Radiation than Surgery
  • Phase 3 Trial Testing New Imaging Agent for Prostate Cancer Detection Doses First Patient
  • New Imaging Agent Better at Detecting Signs of Prostate Cancer Recurrence, Study Reports
  • ADT Increases Risk for Fractures in Older Prostate Cancer Patients, Study Shows
  • Finasteride Use Before Prostate Cancer Diagnosis Linked to More Advanced Disease, Lower Survival, Study Finds